Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

37.55 -0.41 (-1.07%)
Streaming Delayed Price Updated: 3:01 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,204,517
Open 37.65
Bid (Size) 37.53 (3)
Ask (Size) 37.56 (2)
Prev. Close 37.95
Today's Range 37.30 - 38.57
52wk Range 36.73 - 71.85
Shares Outstanding 54,313,676
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire

Performance

YTD
-42.91%
-42.91%
1 Month
-20.42%
-20.42%
3 Month
-35.23%
-35.23%
6 Month
-35.64%
-35.64%
1 Year
-41.17%
-41.17%

More News

Read More
Inari Medical to Announce First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
What 8 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Inari Medical
Via Benzinga
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
From Inari Medical, Inc.
Via GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
Via The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.